Anhui Toneker Biotechnology Co.,Ltd.

Toneker BioTech is a high-tech In-Vitro Diagnostics enterprise integrating research and development, production and sale of clinical test reagents and instruments. Our core competences have been in the fields of molecular and immune technologies. We have always taken innovation as the underlying driving force for enterprise development, with our high-end R&D team including academicians of the Chinese Academy of Sciences and chief scientist of the National 973 Project as consultants, as well as the multi-level support systems such as "Tongji University Talent Training and Industry-University-Research Cooperation Base", "Academician Workstation", "Postdoctoral Innovation Practice Base", etc.We have established independent research and development platforms such as enzyme protein technology platform, multi color fluorescence quantitative PCR technology platform, chemiluminescence technology platform, and stem cell technology platform.At present, the company's R&D production line covers the fields of maternal and child health, infectious diseases, individualized medication, tumor screening, cytokines and so on. We have over 15000 square meters of operating research and production bases in Shanghai Tongji University Science and Technology Park, Suzhou Biological Nano Park, Anhui Jinzhai, and other places. We have clean production workshops that comply with national medical device production quality management standards,as well as advanced research and production equipments.We have provided services and products to nearly 100 hospitals and testing institutions.Together with our business partners, industrial organizations, university research institutions, we will build a shared and win-win ecosystem to jointly contribute to the construction of China’s healthcare system. Cultivate both internally and externally, strive for stability and progress.Going forward, we will seize the opportunities of national development, increase investment in research, build a new precision medical industry chain for disease prevention, diagnosis , and cell therapy. We will create a most promising health ecosystem to achieve win-win results for enterprises, medical institutions and society.